Market closed

uniQure/$QURE

14:30
16:10
17:45
19:25
21:00
1D1W1MYTD1Y5YMAX

About uniQure

uniQure NV is a gene therapy company. It develops treatments and platforms for patients suffering from genetic and other devastating diseases. Its products and services are focused on hemophilia, Huntington's disease, and cardiovascular diseases. The company is focused on the development of the pipeline of gene therapies with the collaboration of Bristol Myers Squibb for cardiovascular diseases.

Ticker

$QURE
Trading on

Industry

Biotechnology

Employees

480

uniQure Metrics

BasicAdvanced
$754M
Market cap
-
P/E ratio
-$4.95
EPS
0.90
Beta
-
Dividend rate
$754M
0.9
$17.40
$3.73
3.4M
6.512
6.181
877.779
889.828
-3.12%
-16.42%
-147.56%
26.186
13.51
-16.8
-4.051
-74.45%
2.77%
-61.49%
-10.62%

What the Analysts think about uniQure

Analyst Ratings

Analyst ratings (Buy, Hold, Sell) for uniQure stock.

uniQure Financial Performance

Income Statement

Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%

uniQure Earnings Performance

Earnings per share (EPS)

Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy $QURE

$

Sign up or log in to buy
Capital at risk
Market closed

Upcoming events

No upcoming events

FAQs

What’s the current market cap for uniQure stock?

uniQure (QURE) has a market cap of $754M as of December 21, 2024.

What is the P/E ratio for uniQure stock?

The price to earnings (P/E) ratio for uniQure (QURE) stock is 0 as of December 21, 2024.

Does uniQure stock pay dividends?

No, uniQure (QURE) stock does not pay dividends to its shareholders as of December 21, 2024.

When is the next uniQure dividend payment date?

uniQure (QURE) stock does not pay dividends to its shareholders.

What is the beta indicator for uniQure?

uniQure (QURE) has a beta rating of 0.9. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.